Intellectual Outcome After Reduced-Dose Radiation Therapy Plus Adjuvant Chemotherapy for Medulloblastoma: A Children’s Cancer Group Study
- 1 August 2001
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (15), 3470-3476
- https://doi.org/10.1200/jco.2001.19.15.3470
Abstract
PURPOSE: To investigate the intellectual outcomes of children with medulloblastomas/primitive neuroectodermal tumors (MB/PNET) treated with reduced-dose craniospinal radiotherapy (RT) plus adjuvant chemotherapy. PATIENTS AND METHODS: Forty-three children with average-risk posterior fossa MB/PNETs underwent longitudinal intelligence testing. All had been treated with a reduced-dose craniospinal RT regimen (23.4 Gy to the neuraxis, 32.4-Gy boost to the posterior fossa) and adjuvant chemotherapy. RESULTS: The estimated rate of change from baseline was significant for Full Scale Intelligence Quotient (FSIQ), Verbal IQ (VIQ), and Nonverbal IQ (NVIQ) (P < .001 for all three outcomes). The rate of change was estimated to be −4.3 FSIQ points per year, −4.2 VIQ points per year, and −4.0 NVIQ points per year. Females were more subject to VIQ decline than were males (P = .008), and young children (< 7 years of age) were more negatively affected than were older children, with a significant decline in NVIQ (P = .016). Finally, patients with higher baseline evaluations suffered greater declines in IQ than did those with lower baseline scores. CONCLUSION: This study represents the largest series of patients with average-risk MB/PNETs treated with a combination of reduced-dose RT and adjuvant chemotherapy whose intellectual development has been followed prospectively. Intellectual loss was substantial but suggestive of some degree of intellectual preservation compared with effects associated with conventional RT doses. However, this conclusion remains provisional, pending further research.Keywords
This publication has 14 references indexed in Scilit:
- Treatment of Children With Medulloblastomas With Reduced-Dose Craniospinal Radiation Therapy and Adjuvant Chemotherapy: A Children's Cancer Group StudyJournal of Clinical Oncology, 1999
- Results of a Prospective Randomized Trial Comparing Standard Dose Neuraxis Irradiation (3,600 cGy/20) with Reduced Neuraxis Irradiation (2,340 cGy/13) in Patients with Low-Stage MedulloblastomaPediatric Neurosurgery, 1996
- Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International society of paediatric oncology (SIOP) and the (German) society of paediatric oncology (GPO): SIOP IIMedical and Pediatric Oncology, 1995
- Long-term neurobehavioral outcome in pediatric brain-tumor patients: Review and methodological critiqueJournal of Clinical and Experimental Neuropsychology, 1994
- Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score.Journal of Clinical Oncology, 1992
- Medulloblastoma in childhood: progressive intellectual deteriorationChild's Nervous System, 1990
- LATE EFFECTS OF CENTRAL NERVOUS SYSTEM TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDHOOD ARE SEX‐DEPENDENTDevelopmental Medicine and Child Neurology, 1990
- Quality of Life in Children with Primitive Neuroectodermal Tumors (Medulloblastoma) of the Posterior FossaPediatric Neurosurgery, 1987
- Late effects of radiotherapy on patients with cerebellar medulloblastomaCancer, 1984
- Age at treatment and long-term performance results in medulloblastomaCancer, 1984